Age does not influence efficacy of ramucirumab in advanced gastric cancer: Subgroup analyses of REGARD and RAINBOW.
J Gastroenterol Hepatol
; 33(4): 814-824, 2018 Apr.
Article
in En
| MEDLINE
| ID: mdl-28960444
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Stomach Neoplasms
/
Adenocarcinoma
/
Antineoplastic Combined Chemotherapy Protocols
/
Randomized Controlled Trials as Topic
/
Clinical Trials, Phase III as Topic
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Gastroenterol Hepatol
Journal subject:
GASTROENTEROLOGIA
Year:
2018
Type:
Article
Affiliation country:
Japan